Christine A Tsingos insider trades: Bio-Rad Laboratories (BIO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christine reports to the SEC
and 1 more company
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 14, 2018 | BIO | ↓ Sell | 1,411 | $248.00 | $350K | Direct | Dec 17, 2018 (3d) |
| Dec 14, 2017 | BIO | ↓ Sell | 4,980 | $249.40 | $1.2M | Direct | Dec 14, 2017 (0d) |
| Mar 14, 2016 | BIO | ↓ Sell | 6,230 | $137.67 | $858K | Direct | Mar 14, 2016 (0d) |
| Sep 14, 2015 | BIO | ↓ Sell | 289 | $138.26 | $40K | Direct | Sep 14, 2015 (0d) |
| Sep 9, 2015 | BIO | ↓ Sell | 76 | $139.01 | $11K | Direct | Sep 10, 2015 (1d) |
| Mar 12, 2015 | BIO | ↓ Sell | 5,400 | $135.94 | $734K | Direct | Mar 12, 2015 (0d) |
| Nov 20, 2014 | BIO | ↓ Sell | 1,326 | $115.85 | $154K | Direct | Nov 20, 2014 (0d) |
| Nov 12, 2014 | BIO | ↓ Sell | 7,000 | $112.22 | $786K | Direct | Nov 13, 2014 (1d) |
| Sep 10, 2012 | BIO | ↓ Sell | 77 | $103.49 | $8K | Direct | Sep 11, 2012 (1d) |
| Jun 12, 2012 | BIO | ↓ Sell | 74 | $96.51 | $7K | Direct | Jun 13, 2012 (1d) |
| Jun 11, 2012 | BIO | ↓ Sell | 74 | $96.49 | $7K | Direct | Jun 12, 2012 (1d) |
| Sep 9, 2011 | BIO | ↓ Sell | 75 | $94.85 | $7K | Direct | Sep 12, 2011 (3d) |
| Jun 14, 2011 | BIO | ↓ Sell | 75 | $117.53 | $9K | Direct | Jun 15, 2011 (1d) |
| Jun 13, 2011 | BIO | ↓ Sell | 74 | $117.30 | $9K | Direct | Jun 14, 2011 (1d) |
| Mar 4, 2011 | BIO | ↓ Sell | 4,692 | $115.50 | $542K | Direct | Mar 7, 2011 (3d) |
| Nov 18, 2010 | BIO | ↓ Sell | 9,000 | $95.03 | $855K | Direct | Nov 18, 2010 (0d) |
| Aug 4, 2009 | BIO | ↓ Sell10b5-1 | 74 | $76.00 | $6K | Direct | Aug 5, 2009 (1d) |
| Jun 12, 2009 | BIO | ↓ Sell10b5-1 | 73 | $74.80 | $5K | Direct | Jun 16, 2009 (4d) |
| Aug 14, 2008 | BIO | ↓ Sell | 4,808 | $105.55 | $507K | Direct | Aug 15, 2008 (1d) |
| Aug 15, 2007 | BIO | ↓ Sell | 3,000 | $80.28 | $241K | Direct | Aug 16, 2007 (1d) |
| Sep 5, 2006 | BIO | ↓ Sell | 3,500 | $73.66 | $258K | Direct | Sep 6, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christine A Tsingos's insider trades
Christine A Tsingos is EVP and CFO at Bio-Rad Laboratories (BIO). Since Sep 5, 2006, Christine has reported no open-market purchases and 21 sales worth $6.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (0% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (43 filings), grants and awards (42 filings), shares withheld for taxes (15 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.